Is BDTX undervalued or overvalued?
As of 2025-03-15, the Intrinsic Value of Black Diamond Therapeutics Inc (BDTX) is -6.46 USD. This BDTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.65 USD, the upside of Black Diamond Therapeutics Inc is -491.43%. This means that BDTX is overvalued by 491.43%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -6.46 - -6.46 | -6.46 | -491.43% |
P/E | (13.15) - (29.89) | (21.06) | -1376.1% |
DDM - Stable | (9.29) - (37.01) | (23.15) | -1502.8% |
DDM - Multi | (0.17) - (0.51) | (0.26) | -115.5% |
Market Cap (mil) | 93.37 |
Beta | 2.78 |
Outstanding shares (mil) | 56.59 |
Enterprise Value (mil) | 69.95 |
Market risk premium | 4.60% |
Cost of Equity | 10.44% |
Cost of Debt | 5.00% |
WACC | 7.05% |